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Background: Chronic obstructive pulmonary disease (COPD) is under-diagnosed and
diagnosis often occurs late thereby reducing opportunities to prevent deterioration.
Investigation of causes has focused on the use of spirometry but the role of attitudes of
doctors and patients has not been directly investigated.
Methods: A cross-sectional study of patients diagnosed with COPD and their general
practitioners in two general practices in Tasmania who participated in semi-structured
interviews and focus groups. Practice records were examined and patients underwent
spirometry, quality of life and symptom assessment. Iterative content analysis identified
themes that were compared with quantitative data.
Findings: For the 32 participating patients, mean recorded duration of COPD was 8.0
(SD 6.8) years and mean FEV1% predicted 38.4% (SD 19.8). Qualitative data were obtained
from 14 (44%) of patients with COPD (5M/9F) and 16 general practitioners (GPs) (10M/6F).
We identified three themes around the diagnosis of COPD in primary care: patients’ labels,
acquiring and communicating a diagnosis and consequences of delaying or withholding
diagnosis. Doctors correctly recognised that patients were unfamiliar with COPD. They
intentionally avoided early diagnosis as a result of nihilism and misperception of patients’
attitudes. Patients often received the diagnosis from other sources and found delayed
diagnosis frustrating.
Interpretation: Nihilistic attitudes to COPD may explain the disappointing results from
promotion of spirometry in primary care. Education about COPD for doctors in primary care
is needed and action to increase awareness and understanding of COPD in the community.
& 2008 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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Under-diagnosis of chronic obstructive pulmonary disease 739Introduction aimed for a non-probability sample of 20 participants with aPrevious studies have found that chronic obstructive
pulmonary disease (COPD) is both under-diagnosed and
diagnosed late in primary care.1,2 Earlier diagnosis would
increase the opportunity for intervention, especially
through smoking cessation,3 which confers greatest benefit
the earlier it is achieved.4 Spirometry is required for the
diagnosis of COPD,5,6 particularly in its early stages, as
reliance on symptoms will miss up to 50% of cases.7 We have
previously reported on the low rate of use of spirometry in
the diagnosis of COPD in primary care,8 but little is known
about other barriers to its early diagnosis due to attitudes of
patients or doctors. Qualitative research, with its inductive
and interpersonal nature,9 is well suited to exploring
barriers and providing new insights that can improve
practice. In this study we investigated attitudes influencing
the diagnosis of COPD amongst doctors and patients with
COPD in a primary care setting.
Methods
Selection of participants
Nineteen general practitioners (GPs) in two practices in
Southern Tasmania were invited to participate and asked to
select patients they recognised as having COPD from
searches of practice databases using COPD diagnosis or
repeat prescriptions for respiratory medications. Patients
with cognitive impairment or another serious medical
condition were excluded. Subjects were invited to partici-
pate by letter. Informed consent was obtained from
respondents and GPs. The study was approved by the
Southern Tasmanian Health and Medical Human Research
Ethics Committee (2002 H006650).
Clinical assessment
Participating patients underwent spirometry with bronchodi-
lator reversibility testing10 using European Community for
Steel and Coal reference values,11 data collection on
demographics and smoking history. They completed the
anxiety and depression questionnaire for general medical
settings,12 the St. George’s Respiratory Quality of Life
Questionnaire (SGRQ)13 and MRC functional dyspnoea scale.14
COPD was diagnosed by a post-bronchodilator FEV1/FVC ratio
o0.76 with severity determined by FEV1% predicted: mild
X80%, moderate 50–79%, severe 30–49%, very severeo30%.15
Practice records were reviewed to extract data from the time
of diagnosis and subsequently using a structured template.
Interviews with patients
Interviews were conducted at participants’ homes before
clinical assessments to avoid bias through contact with
researchers. An interview guide based on open-ended
questions for eliciting an explanatory model was used in
semi-structured interviews (see Appendix A) with additional
reminder prompts for the interviewer to explore issues not
spontaneously mentioned by the interviewee.16 The studybalance of gender, age and geographical location.17
Focus groups with general practitioners
All doctors in the involved practices were invited to
participate in an interview or focus group lasting from 60
to 90min conducted during working hours at doctors’
premises. An experienced facilitator used interview prompts
and questions (Appendix A) to guide discussions exploring
attitudes to the diagnosis and management of COPD.
Data analysis
Interviews and focus group discussions were recorded and
transcribed verbatim. Transcripts were analysed indepen-
dently by two authors (JW and EH) within an iterative
interpretive framework drawing on aspects of grounded
theory.18 Each transcript was read as soon as possible after
the interview and given initial codes and memos. Notice was
paid to repeated stories and links made between events and
illness and how participants spoke about the diagnosis. This
iterative process was repeated as more interviews were
conducted and transcripts were then compared with each
other. Codes were grouped into larger categories and after
ongoing iteration these categories were grouped into major
themes. The process of analysis was performed using NVivo
(version 2, Qualitative Solutions & Research International,
Melbourne, Vic.). Emergent themes were verified by JW and
EH and discussed among all authors, while a more detailed
in-depth analysis of some thematic areas was performed
independently by JW and EH.19,20
Quantitative results were analysed using SPSS. Variables
are presented as mean and standard deviation (SD) if
normally distributed or median and interquartile range
(IQR) for non-normal distribution. Continuous variables were
compared between groups using Student’s t-test or Man-
n–Whitney U-test. Chi square tests were used to compare
categorical variables.
Results
Recruitment
Of 106 patients identified by searches, 32 patients with
COPD completed clinical assessments of whom 14 patients
underwent interview, nine from an urban and five from a
rural/suburban practice (Figure 1). Three interviewees did
not complete clinical assessments (one required treatment
for another condition and two said their respiratory
symptoms were too severe) thus no comparisons can be
made between these patients and those whose data were
analysed. Four interviewees were subsequently found to
have been incorrectly classified with COPD (two had asthma
and two had chronic bronchitis without airflow limitation).
Their interview data are not included in this analysis.
Amongst the 32 participants with COPD, 13 (41%) were
male and 27 (84%) were ex-smokers (Table 1). The dates of
diagnosis were unavailable in five patient records and eight
patients did not provide dates. COPD was classified as: mild
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Table 1 Characteristics of participants with COPD
according to participation in semi-structured interviews.
Participant characteristics Interviewed
(n ¼ 14)
No interview
(n ¼ 18)
Male (%) 5 (35.7) 8 (44.4)
Ex-smoker (%) 10 (71.4) 15 (83.3)
Age (years),y 67.0 (16.0) 72.5 (15.0)
Duration COPD patient
report (years)
12.0 (9.5) 9.5 (9.8)
Duration COPD practice
record (years)
5.5 (11.3) 9.0 (7.3)
Smoking exposure (pack
years)z
55.21 (26.2) 66.7 (23.1)
Years smoking pre-diagnosisz 40.57 (11.0) 42.40 (8.4)
FEV1% predicted
y 38.4 (19.8) 52.9 (14.5)
FEV1/FVC ratio 0.50 (0.21) 0.61 (0.13)
SGRQ score: overallz 52.3 (24.5) 47.8 (16.1)
SGRQ score: activity
limitationz
67.9 (31.3) 64.3 (21.7)
SGRQ score: symptomsz 66.7 (23.9) 64.6 (19.6)
SGRQ score: impactsz 38.8 (23.8) 31.2 (17.5)
Functional dyspnoea (MRC
grade)z
3.1 (1.7) 2.7 (1.3)
Anxiety screening: positive
(%)
8 (57.1) 7 (38.9)
Depression screening:
positive (%)
9 (64.3) 13 (72.2)
SGRQ, St. George’s Respiratory Questionnaire.
Median (IQR).
ypo0.05.
zMean (SD).
J.A. Walters et al.7402 (6%), moderate 13 (41%), severe 9 (28%) and very severe 8
(25%). The mean duration of COPD from practice records
was 7.9 (6.4) years and from patient report 10.0 (6.9) years.
Participants who were interviewed were younger (mean
difference 8 years, SE 3) with more severe airflow limitation
(mean difference FEV1% predicted 15, SE 6) than those not
interviewed. However, there were no significant differences
in quality of life, functional dyspnoea or presence of
symptoms of anxiety and depression (Table 1).
Sixteen (84%) GPs provided qualitative data (10M/6F),
their length of time in practice ranged from 5 to 30 years.
Findings
This study revealed findings about the diagnosis of COPD in
primary care in three thematic areas which we titled: 1.
Patients’ labels, 2. Acquiring and communicating a diag-
nosis, 3. Consequences of delaying or withholding diagnosis.
Patients’ labels
The diagnosis of COPD was rarely named directly by any
patient. When asked to describe their illness, 13 inter-
viewees used the term emphysema, one used COPD in
addition to emphysema and one called it asthma. The
diagnosis was rarely given as a direct, specific answer.
Frequently it was qualified with a description of another
perceived prior respiratory condition, usually ‘‘asthma’’:
I think it is classed as emphysema but it is basically COPD.
Asthma, all that sort of thing it stems from. It started off
as asthma. As I got older it progressed onto bigger titles.
(Female, 49)
It was also common for the diagnosis given by health
professionals to vary over relatively short periods of time:
Well I was originally given the tag of asthma. We were
travelling and my condition got worse. Eventually, I think
they’d probably diagnosed emphysema and asthma.
(Male, 69)Figure 1 Recruitment of patients and general practitioPatients used diagnostic terms interchangeably to de-
scribe their own symptoms:
The emphysema has I think brought on the bronchitis.
Before the bronchitis sets in I get a lot of coughing, so youners in a qualitative study of COPD in primary care.
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the bronchitis. (Female, 76)
GPs themselves noted that changes in diagnostic termi-
nology used by specialist respiratory groups during their
working life were confusing for them and difficult to explain
to patients.
From the population point of view changes just confuse
them. If you say emphysema, they say ‘Oh, that’s what
you’re really talking about!’ They won’t have heard of
COAD, and they certainly wouldn’t have heard of COPD.
(Female GP)
GPs would generally use the term ‘‘emphysema’’ to a
patient when they made a diagnosis of COPD as they felt
patients were familiar with emphysema but did not under-
stand the acronym.
Acquiring and communicating a diagnosis
Consideration of a diagnosis of COPD in the presence of risk
factors, especially smoking, was part of GPs’ diagnostic
process:
If someone has been smoking for say 20 years, they are
going to have some element of COPD. (Male GP)
However they were reluctant to label the condition. This
stemmed mainly from the GPs’ perceived implications of a
diagnosis of emphysema for a patient, who would under-
stand it as a serious, ultimately terminal disease:
You don’t actually say they have emphysema, they are
not keen to have that. They don’t like emphysema; they
have seen Grandad starved of oxygen. I find that they will
fight that label. (Female GP)
Formal diagnosis was often delayed as no apparent
advantage was seen by GPs in applying the diagnosis:
I don’t suppose it really matters whether one puts a label
to it. (Male GP)
Treatment was usually initiated before formal diagnosis of
the emerging clinical picture by the GP:
Gradually a picture evolves- patients chronically short of
breath, tend to have cough and wheeze, who perhaps
benefit from bronchodilators and Atrovent regularly
rather than just during exacerbations. (Male GP)
Delayed recording of a diagnosis was evident with the
duration since diagnosis being greater according patients’
reports than from practice records in 14 (64%) of 22 patients
with available data. The mean discrepancy was 5.4 years
(range 3–15) and among these patients, seven (50%)
screened positively for clinical depression at the time of
this study.
Eventually, formal diagnosis often resulted from admis-
sion to hospital for an acute exacerbation of COPD:
They get crook and get admitted to hospital and come
back with a diagnosis. (Male GP)
Extraction of data from practice records contemporary
with the time of diagnosis was possible for 10 participantsand this confirmed that of those seven had the diagnosis of
COPD made in hospital. More unusually, the diagnosis
resulted from the process of ‘‘gradual evolution’’ in patients
being seen regularly:
It’s just something that dawns on us after a while.
(Male GP)
Even after the diagnosis had become clear in the GP’s
mind, this may have been withheld from the patient, with
eventual disclosure occurring incidentally via a pharmacist
or allied health practitioner.
Well no one actually told me I had it. One day they gave
me the Atrovent and I said ‘This is a new one’ and they
said ‘That is for your emphysema.’ (Female, 50)
Negative personal assessments of COPD were held by GPs
and this could influence them against communicating the
diagnosis:
(COPD) is a horrible way to spend the last 10 or 15 years
of your life. (Male GP)
Diagnosis was often preceded by frequent presentation by
patients to a GP:
I think you see a lot of people over a period of time, who
are perhaps in the middle period of life, who might have
recurrent respiratory infections- smokers. (Male GP)
The delay in communicating the diagnosis is supported by
discrepancies in the time since diagnosis. The duration in
practice records exceeded patient-reported duration for
5/22 (23%) patients, mean difference 7.4 years (range
1–12). Of these patients at the time of study, all had clinical
depression on screening.
Overall quality of life scores and individual domain scores
for symptoms, activity limitations or impacts did not differ
significantly between patients with discrepant or non-
discrepant disease duration.Consequences of delaying or withholding a diagnosis
Patients expressed frustration when not given a diagnosis.
Delay meant doctors often failed to provide information
about COPD, causing patients to seek information else-
where, or remain poorly informed:
I read up in a couple of medical books. I have been like
this for two or three years and no one actually told me I
had emphysema. (Female, 50)
I don’t really know that much about it. I haven’t really
had it explained to me. (Male, 55)
A major disadvantage of withholding a diagnosis is
potentially losing the opportunity for preventing deteriora-
tion by achieving smoking cessation. GPs appeared pessi-
mistic that a diagnosis of COPD could assist patients to stop
smoking:
The percentage of patients diagnosed with COPD that
have stopped smoking are far less than those diagnosed
with ischaemic heart disease. (Male GP)
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any smoker, but felt smokers with COPD were difficult to
motivate:
They all imagine that they will have a heart attack or get
lung cancer, and they don’t think from fifty onwards they
will not be able to walk down the street. (Female GP)
However patients referred positively to their doctors’
advice to quit smoking:
The doctor told me ‘Smoke or die’. So I gave up. That is
when I first had an outbreak of emphysema. (Female, 60)
Patients universally recognised the difficulty of quitting
smoking, and were apologetic if they continued to smoke
yet were still receptive to advice:
‘If I had a doctor telling me I had to give it up it would
give me a bit of a shock, but I just can’t tell myself to do
it.’ (Female, 60)Discussion
This study found that making a diagnosis of COPD by doctors
in primary care is often delayed, and that this delay may be
intentional. There was also evidence that even after the
diagnosis had been made, this was not communicated to
patients. These findings were consistent with both the
expressed attitudes and clinical practice of doctors and
reports of patients’ experiences.
The delayed diagnosis of COPD differed from some other
chronic diseases such as hypertension, where under-diag-
nosis is likely to be due to conflicting diagnostic criteria.21 In
COPD, the delay was rationalised by misperception of
patients’ unwillingness to be given a diagnosis and doctors’
pessimistic attitudes to prognosis. Similar communication
deficits in COPD between primary care physicians and
patients were found in the US22 and in Spain where only
11.2% of smokers or ex-smokers had any spontaneous
knowledge of COPD.23 Perhaps the reluctance on the part
of GPs was to protect patients against psychological impact
in a population in whom depression and anxiety are
common.24
Although doctors perceived their advice on smoking
cessation to be relatively ineffective, this was not generally
supported by participants who assessed it as valuable. Other
studies have shown that doctors may be reluctant to give
advice on smoking cessation for fear of harming the
doctor–patient relationship or because of a preference for
addressing the patient’s agenda.25
The strengths of this study included the use of data from
practice records to validate patient-reported experience
and the direct comparison of the attitudes of patients with
those of their doctors.17 Participating patients were
symptomatic, had significantly impaired quality of life and
moderate or severe disease. This reflects the general
situation in primary care in Australia, where patients with
mild disease are less likely to be diagnosed.26
There are limitations to the study. We may not have
identified the entire COPD population in the practices,
firstly due to the response rate, although this is line with
previous studies27,28 and secondly because of incompleterecording of the diagnosis.29 To overcome the latter, we
supplemented our search using respiratory medication use,
resulting in an age distribution in our sample similar to that
in a UK practice cohort.29
The number of patient interviews available for analysis
was constrained by substantial misclassification, although
the rate (22%) was similar to that found in a study of UK
general practice.29 Although this reduced the number of
patient interviews available for qualitative analysis, themes
that emerged were consistent between interviewees.17
We believe our findings are representative of Australian
general practice, despite the majority of participants being
female. An Australian prevalence study in 1998 found self-
reported emphysema to be only marginally more prevalent
in males than females.30 In assessing time of diagnosis, it is
acknowledged that patients’ recall of diagnosis was sub-
jective and may not have been accurate. However the high
proportion of patients (86%) with discrepancies in duration is
striking.
There was no reason to expect that this sample of doctors
would differ from others in their clinical practice, as
they were not selected on the basis of having a special
interest in chronic respiratory diseases. These findings are
likely to be generalisable to general practice in Australia as
a whole and relevant to similar systems of primary care
internationally.
There have been disappointing results from efforts to
increase the use of spirometry in primary care and achieve
earlier diagnosis of COPD.31,32 These results indicate that
attitudes of GPs to the diagnosis of COPD are also an
important cause of diagnostic delay. They highlight the need
for education about the nature, natural history and
treatment of COPD for GPs to reduce their nihilism and for
efforts to increase awareness and understanding of COPD in
the community.
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